Quantcast
Last updated on April 16, 2014 at 5:23 EDT

Latest chemotherapy Stories

Alzheimer’s Disease And Dementia Explored In New Studies
2013-07-15 18:11:26

Brett Smith for redOrbit.com- -Your Universe Online Alzheimer's disease affects millions of Americans and two new studies have uncovered interesting information about the disease. In one study of almost 500,000 French men and women, people who delayed retirement were found to have less of a risk of developing Alzheimer's or other types of dementia. In the other study of 3.5 million US military veterans, those diagnosed with cancer were less likely to have Alzheimer's and those who...

2013-07-15 10:30:03

Although women who survived childhood cancer face an increased risk of infertility, nearly two-thirds of those who tried unsuccessfully to become pregnant for at least a year eventually conceived, according to clinical researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Brigham and Women's Hospital. This is comparable to the rate of eventual pregnancy among all clinically infertile women. "Most women think that if they had cancer as a child, then they'll...

2013-07-12 23:16:53

Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, commends Shelli Kesler and her team of researchers for conducting a study that could help cancer survivors with their mental recovery. New York, NY (PRWEB) July 12, 2013 On July 12, Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, commends Shelli Kesler, a Stanford University clinical neuropsychologist, and her colleagues for using brain-training...

2013-07-11 16:24:45

Patient, physician and patient advocate representatives discuss innovations in personalized medicine and its impact on the future of health care WASHINGTON, July 11, 2013 /PRNewswire-USNewswire/ -- Results for Life (RFL), the educational branch of the American Clinical Laboratory Association, today convened a briefing on Capitol Hill to highlight the value and innovations taking place in the field of genetic and genomic testing. These tests mark the advent of personalized medicine -...

2013-07-11 16:05:38

Indication of considerable added benefit for overall survival / indications of greater harm from side effects The drug aflibercept (trade name: Zaltrap) has been approved in Germany since February 2013 in combination with a certain chemotherapy for adults with metastatic colorectal cancer in whom chemotherapy with oxaliplatin could not stop the disease from progressing. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG) the German...

2013-07-10 08:26:32

May enable treatment of patients previously deemed untreatable WESTMINSTER, Colo., July 10, 2013 /PRNewswire/ -- Case reports published in the Journal of Cardiovascular and Interventional Radiology found that by using the Surefire Infusion System, radioembolization could be successfully performed without the need to protect nearby blood vessels, a significant advance that may enable doctors to safely extend liver cancer treatment to patients who were previously deemed untreatable....

2013-07-09 21:24:33

New evidence suggests that using advanced genetics technologies to monitor for remaining cancer cells after treatment may soon become an effective tool to inform treatment decisions and ultimately predict patient outcomes for patients with a particularly aggressive form of acute lymphocytic leukemia (ALL). Study results were published online today in Blood, the Journal of the American Society of Hematology (ASH). Approximately 25 to 30 percent of all adults with ALL, the second most common...

2013-07-09 12:27:34

WASHINGTON, July 9, 2013 /PRNewswire-USNewswire/ -- New evidence suggests that using advanced genetics technologies to monitor for remaining cancer cells after treatment may soon become an effective tool to inform treatment decisions and ultimately predict patient outcomes for patients with a particularly aggressive form of acute lymphocytic leukemia (ALL). Study results were published online today in Blood, the Journal of the American Society of Hematology (ASH). Approximately 25...

2013-07-09 08:27:54

Dr. Michael Har-Noy, founder and CEO of Immunovative Therapies, a biotech company in Israel, discusses a unique approach to cancer treatment, in which its cellular-based drugs stimulate the host immune system to target and kill malignant cells. NEW YORK, July 9, 2013 /PRNewswire-iReach/ -- The most promising way to develop curative treatment that eliminates every cancer cell in a patient, says Dr. Michael Har-Noy, founder and CEO of Immunovative Therapies Ltd., would be by...

2013-07-02 23:27:26

Easier access to ultrasound services may enable earlier cancer diagnosis for treatment Austin, TX (PRWEB) July 02, 2013 Oncura Partners Holdings, Inc. is proud to announce the launch of Oncura Partners Diagnostics, LLC (OP Diagnostics), which will provide remote ultrasound services to veterinarians . OP Diagnostics recently signed an exclusive distribution agreement for the SonixTablet, which is the only ultrasound product available today with real-time telemedicine. The SonixTablet is...


Latest chemotherapy Reference Libraries

Intravenous Therapy
2013-04-30 13:16:16

Intravenous therapy, commonly known as IV therapy, is known as the administration of a liquid substance directly into a vein. It is also known as drip therapy, because most often the liquid is suspended above the IV site by an infusion pump, and runs through a drip chamber, which prevents air from entering the line. IVs are the preferred method of drug administration in hospital settings because they are the fastest known route of getting medication to the body. Intravenous therapy can also...

Antiviral Chemistry & Chemotherapy
2012-04-25 09:59:26

Antiviral Chemistry & Chemotherapy is a peer-reviewed academic journal published bi-monthly by International Medical Press in London since 1997. When founded in January 1990, it was published by Blackwell Science. The current editor-in-chief is Hugh J. Field of University of Cambridge, UK. The journal publishes primary papers and reviews on all aspects of the preclinical development of antiviral agents, including their chemical synthesis, biochemistry, pharmacology, mode of action and...

More Articles (2 articles) »